CAM
DNA icon

Close Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Close Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28
Closed – – 257
2025
Q1 		$0 Hold
28
– – ﹤0.01% 255
2024
Q4 		$0 Hold
28
– – ﹤0.01% 249
2024
Q3 		$0 Hold
28
– – ﹤0.01% 266
2024
Q2 		$0 Hold
28
– – ﹤0.01% 270
2024
Q1 		$1K Hold
28
– – ﹤0.01% 250
2023
Q4 		$2K Hold
28
– – ﹤0.01% 231
2023
Q3 		$2K Buy
+28
New +$2.24K ﹤0.01% 224
2023
Q2 		– Sell
-55
Closed -$3K – 255
2023
Q1 		$3K Hold
55
– – ﹤0.01% 218
2022
Q4 		$4K Hold
55
– – ﹤0.01% 183
2022
Q3 		$7K Hold
55
– – ﹤0.01% 163
2022
Q2 		$5K Hold
55
– – ﹤0.01% 171
2022
Q1 		$18K Hold
55
– – ﹤0.01% 172
2021
Q4 		$18K Hold
55
– – ﹤0.01% 172
2021
Q3 		$25K Buy
+55
New +$26.8K ﹤0.01% 158

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return